Telix Pharmaceuticals Limited
TLX
$10.68
-$0.06-0.54%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -67.76% | -67.76% | 161.27% | 158.89% | 421.98% |
| Total Receivables | 38.85% | 38.85% | 99.57% | 138.97% | 102.23% |
| Inventory | 56.99% | 56.99% | 71.42% | 181.41% | 85.43% |
| Prepaid Expenses | 89.41% | 89.41% | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | 368.67% | 94.42% | -- |
| Total Current Assets | -42.07% | -42.07% | 133.70% | 148.50% | 259.26% |
|
|
|||||
| Total Current Assets | -42.07% | -42.07% | 133.70% | 148.50% | 259.26% |
| Net Property, Plant & Equipment | 243.61% | 243.61% | 190.62% | 251.16% | 61.31% |
| Long-term Investments | 198.84% | 198.84% | 136.52% | 5,732.96% | -- |
| Goodwill | 198.84% | 198.84% | 136.52% | 5,732.96% | -- |
| Total Other Intangibles | 105.90% | 105.90% | 111.92% | 467.15% | 154.85% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 62.16% | 62.16% | 356.84% | 404.29% | 230.98% |
| Total Assets | 23.78% | 23.78% | 139.09% | 324.38% | 239.17% |
|
|
|||||
| Total Accounts Payable | 69.70% | 69.70% | 247.35% | 273.35% | -22.28% |
| Total Accrued Expenses | 9.79% | 9.79% | 26.76% | 73.80% | 403.10% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 40.19% | 40.19% | 735.21% | 1,431.59% | 1,147.33% |
| Total Finance Division Other Current Liabilities | -12.73% | -12.73% | 53.87% | 241.48% | 118.79% |
| Total Other Current Liabilities | -12.73% | -12.73% | 53.87% | 241.48% | 118.79% |
| Total Current Liabilities | 12.94% | 12.94% | 73.20% | 204.53% | 84.15% |
|
|
|||||
| Total Current Liabilities | 12.94% | 12.94% | 73.20% | 204.53% | 84.15% |
| Long-Term Debt | 14.66% | 14.66% | 5,494.55% | 5,562.08% | 5,649.55% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 1,021.26% | 1,021.26% | 358.16% | 470.34% | -4.00% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 93.06% | 93.06% | 65.94% | 35.93% | -31.79% |
| Total Liabilities | 27.44% | 27.44% | 236.59% | 373.32% | 236.43% |
|
|
|||||
| Common Stock & APIC | 15.93% | 15.93% | 20.72% | 61.27% | 31.36% |
| Retained Earnings | -1.06% | -1.06% | 3.09% | 5.68% | 18.28% |
| Treasury Stock & Other | -2.05% | -2.05% | 198.78% | 758.76% | 461.37% |
| Total Common Equity | 17.69% | 17.69% | 56.55% | 257.15% | 243.84% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 17.69% | 17.69% | 56.55% | 257.15% | 243.84% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 17.69% | 17.69% | 56.55% | 257.15% | 243.84% |
|
|
|||||